Metformin in nonalcoholic steatohepatitis: a randomized controlled trial
{{output}}
BACKGROUNDN onalcoholic steatohepatitis (NASH) is a common liver disease that can progress to cirrhosis or hepatocellular carcinoma. It is estimated that up to 3% of the Iranian population have this condition. Although the pathogenesis of NASH is incompletely ... ...